Brief: Kuros Biosciences Announces U.S. FDA Approval Of IND Application

Kuros Biosciences AG

03/09/2019 06:04

Sept 3 (Reuters) - Kuros Biosciences AG  KURN.S :
    * ANNOUNCES U.S. FDA APPROVAL OF IND APPLICATION TO INITIATE
FIBRIN-PTH PHASE 2A CLINICAL TRIAL IN SPINAL FUSION  KURN.S 

Source text for Eikon:  ID:nTEN5ttrra 
Further company coverage:  KURN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))